Bilayer Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Out of Business

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Out of Business

Bilayer Therapeutics General Information

Description

Operator of a biotechnology company seeks to develop bile acids as first-in-class therapies to treat several diseases of the colon. The company's technology stimulates the body's innate mechanisms for regulating constipation, enabling doctors to treat chronic idiopathic constipation, irritable bowel syndrome with constipation, and other conditions of the colon like Inflammatory bowel disease (IBD), ulcerative colitis, Crohn's disease, type 2 diabetes, obesity and metabolic disorders.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • One Broadway, 14th floor
  • Cambridge, MA 02142
  • United States
+1 (734)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • One Broadway, 14th floor
  • Cambridge, MA 02142
  • United States
+1 (734)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bilayer Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 09-Sep-2025 Completed Out of Business
3. Early Stage VC (Series A) Completed Pre-Clinical Trials
2. Early Stage VC 04-Aug-2023 $300K $3.9M Completed Pre-Clinical Trials
1. Seed Round 13-Sep-2022 $3.6M $3.6M Completed Pre-Clinical Trials
To view Bilayer Therapeutics’s complete valuation and funding history, request access »

Bilayer Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Bilayer Therapeutics’s complete cap table history, request access »

Bilayer Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company seeks to develop bile acids as first-in-class therapies to treat several diseases of
Drug Discovery
Cambridge, MA
3 As of 2024

Boston, MA
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Bilayer Therapeutics Competitors (2)

One of Bilayer Therapeutics’s 2 competitors is Ironwood Pharmaceuticals, a Formerly VC-backed company based in Boston, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ironwood Pharmaceuticals Formerly VC-backed Boston, MA
AstraZeneca Formerly PE-Backed Cambridge, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

Bilayer Therapeutics Patents

Bilayer Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023192221-A1 Forms and compositions of sodium chenodeoxycholate Inactive 29-Mar-2022

Bilayer Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Bilayer Therapeutics FAQs

  • When was Bilayer Therapeutics founded?

    Bilayer Therapeutics was founded in 2020.

  • Where is Bilayer Therapeutics headquartered?

    Bilayer Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Bilayer Therapeutics?

    Bilayer Therapeutics has 3 total employees.

  • What industry is Bilayer Therapeutics in?

    Bilayer Therapeutics’s primary industry is Drug Discovery.

  • Is Bilayer Therapeutics a private or public company?

    Bilayer Therapeutics is a Private company.

  • What is Bilayer Therapeutics’s current revenue?

    The current revenue for Bilayer Therapeutics is .

  • How much funding has Bilayer Therapeutics raised over time?

    Bilayer Therapeutics has raised $17.9M.

  • Who are Bilayer Therapeutics’s competitors?

    Ironwood Pharmaceuticals and AstraZeneca are competitors of Bilayer Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process